Alzheimer's Disease Blood Biomarkers Associated With Neuroinflammation as Therapeutic Targets for Early Personalized Intervention

The definitive diagnosis of Alzheimer's Disease (AD) without the need for neuropathological confirmation remains a challenge in AD research today, despite efforts to uncover the molecular and biological underpinnings of the disease process. Furthermore, the potential for therapeutic interventio...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Sher Li, Zhou, Meikun, Chin, Eunice W. M., Amarnath, Gautami, Cheah, Chee Hoe, Ng, Kok Pin, Kandiah, Nagaendran, Goh, Eyleen L. K., Chiam, Keng-Hwee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Digital Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309434/
https://www.ncbi.nlm.nih.gov/pubmed/35899035
http://dx.doi.org/10.3389/fdgth.2022.875895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309434/
https://www.ncbi.nlm.nih.gov/pubmed/35899035
http://dx.doi.org/10.3389/fdgth.2022.875895

Ejemplares similares